1. ScholarBank@NUS
  2. 1. Staff
  3. Staff Publications
Please use this identifier to cite or link to this item: https://doi.org/10.1128/CVI.00117-10
DC FieldValue
dc.titlePneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster
dc.contributor.authorRussell, F.M.
dc.contributor.authorCarapetis, J.R.
dc.contributor.authorSatzke, C.
dc.contributor.authorTikoduadua, L.
dc.contributor.authorWaqatakirewa, L.
dc.contributor.authorChandra, R.
dc.contributor.authorSeduadua, A.
dc.contributor.authorOftadeh, S.
dc.contributor.authorCheung, Y.B.
dc.contributor.authorGilbert, G.L.
dc.contributor.authorMulholland, E.K.
dc.date.accessioned2014-11-26T09:05:00Z
dc.date.available2014-11-26T09:05:00Z
dc.date.issued2010-12
dc.identifier.citationRussell, F.M., Carapetis, J.R., Satzke, C., Tikoduadua, L., Waqatakirewa, L., Chandra, R., Seduadua, A., Oftadeh, S., Cheung, Y.B., Gilbert, G.L., Mulholland, E.K. (2010-12). Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster. Clinical and Vaccine Immunology 17 (12) : 1970-1976. ScholarBank@NUS Repository. https://doi.org/10.1128/CVI.00117-10
dc.identifier.issn15566811
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/110609
dc.description.abstractThis study was conducted to evaluate the effect of a reduced-dose 7-valent pneumococcal conjugate vaccine (PCV) primary series followed by a 23-valent pneumococcal polysaccharide vaccine (23vPPS) booster on nasopharyngeal (NP) pneumococcal carriage. For this purpose, Fijian infants aged 6 weeks were randomized to receive 0, 1, 2, or 3 PCV doses. Within each group, half received 23vPPS at 12 months. NP swabs were taken at 6, 9, 12, and 17 months and were cultured for Streptococcus pneumoniae. Isolates were serotyped by multiplex PCR and a reverse line blot assay. There were no significant differences in PCV vaccine type (VT) carriage between the 3- and 2-dose groups at 12 months. NP VT carriage was significantly higher (P,
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1128/CVI.00117-10
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentDUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
dc.description.doi10.1128/CVI.00117-10
dc.description.sourcetitleClinical and Vaccine Immunology
dc.description.volume17
dc.description.issue12
dc.description.page1970-1976
dc.identifier.isiut000284686400021
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.